Announcements Trials

Browse Landscape

Phase

Phase NA 11 Phase 2 11 Phase 4 3 Phase 1/2 2 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

OTHER 78 INDUSTRY 64 NETWORK 46 NIH 26 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 42 Gynecologic 29 Breast 23 Thoracic 15 Head & Neck 12 Other hematologic neoplasm 7 Lymphoid 6 CNS 5 Plasma cell 4 Myeloid 4 Genitourinary 4 Dermatologic 3 Tumor-Agnostic 2 Other 2 Endocrine 2 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1 NET 1 Classical hematology 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

trametinib 1 palbociclib 1 olaparib 1 nilotinib 1 glasdegib 1 futibatinib 1 durvalumab 1 dabrafenib 1 ceritinib 1 capmatinib 1 Lapatinib 1 High-Throughput Nucleotide Sequencing 1 Base Sequence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Sarcoma × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡